baber/WOPTO huggingface dataset:
Patent MY-158200-A (MY)
Title: Conjugates for the prevention of treatment of nicotine addiction
Inventor: ANASTASIOU NICKOLAS
IPC: A61P25/30
Filed: 2011-06-03
Abstract: THE PRESENT INVENTION RELATES IN PART TO NICOTINE-DERIVED HAPTEN-CARRIER CONJUGATES OF THE FORMULA (III): WHEREIN M, N, W, -(SPACER)- X* AND Y ARE AS DEFINED IN THE DESCRIPTION. IN CERTAIN EMBODIMENTS, SAID NICOTINE-DERIVED HAPTEN-CARRIER CONJUGATES CAN BE USED TO PREPARE VACCINES FOR THE TREATMENT AND/OR PREVENTION OF NICOTINE ADDICTION.
Patent MY-156633-A (MY)
Title: Tobacco-flavor-releasing material and non-heating type tobacco flavor inhalator containing same
Inventor: MASAHIRO CHIDA
IPC: A24F42/60
Filed: 2011-08-12
Abstract: A TOBACCO-FLAVOR-RELEASING MATERIAL COMPRISING GRANULES WHICH CONTAIN (A) A GROUND TOBACCO MATERIAL, (B) WATER, (C) A MOISTURIZING AGENT COMPRISING A POLYHYDRIC ALCOHOL, (D) AT LEAST ONE PH-ADJUSTING AGENT SELECTED FROM THE GROUP CONSISTING OF POTASSIUM CARBONATE AND SODIUM HYDROGENCARBONATE, AND (E) AT LEAST ONE BINDER SELECTED FROM THE GROUP CONSISTING OF PULLULAN AND HYDROXYPROPYL CELLULOSE.
Patent MY-163795-A (MY)
Title: Elevator system having a sound receiver for capturing solid-borne sound
Inventor: WEINBERGER KARL
IPC: B66B5/00
Filed: 2011-11-22
Abstract: THE INVENTION RELATES TO AN ELEVATOR SYSTEM (10) HAVING A CAR (1), A COUNTERWEIGHT (2) BALANCING OUT THE CAR (1), AND A SUPPORT AND/OR DRIVE MEANS (3) ON WHICH THE CAR (1) AND THE COUNTERWEIGHT (2) ARE SUSPENDED. THE ELEVATOR SYSTEM IS CHARACTERIZED IN THAT A SOUND RECEIVER (8) IS COUPLED TO THE ELEVATOR SYSTEM (10) AND IS DESIGNED TO CAPTURE SOLID-BORNE SOUND GENERATED AT THE COUNTERWEIGHT (2).
Patent MY-165822-A (MY)
Title: Method for stopping operation of reactor
Inventor: SHINYA ARAI
IPC: C10G2/00
Filed: 2012-03-15
Abstract: METHOD FOR STOPPING OPERATION OF REACTOR The method for stopping operation of a reactor is provided with a stop step of stopping supply of a synthesis gas containing a carbon monoxide gas and a hydrogen gas into the reactor; a slurry discharge step of discharging slurry from the reactor; a steam supply step of supplying steam higher in temperature than the decomposition temperatures of metal carbonyls into the reactor, thereby discharging gaseous matters inside the reactor; and a carbon monoxide gas detecting step of detecting an amount of carbon monoxide gas contained in the gaseous matters discharged from the reactor. In the steam supply step, supply of the steam is stopped when an amount of the detected carbon monoxide gas continuously declines to be lower than a predetermined reference value. FIG .1
Patent MY-175758-A (MY)
Title: Control device for cooling system
Inventor: OHASHI NOBUMOTO
Filed: 2011-12-19
Abstract: A device (100) that controls a cooling system  (500) including adjusting means for being able to adjust a circulation amount of coolant in a first flow passage, including an engine cooling flow passage (CCVi1), an EGR cooling flow passage (CCVo2) and a radiator flow passage, and a second flow passage, including the engine cooling flow passage (CCVi1), the EGR cooling flow passage (CCVo2) and a bypass flow passage and not including the radiator flow passage, includes: measuring means for measuring a temperature of the coolant; limiting means for limiting circulation of the coolant at starting an internal combustion engine; and control means for circulating the coolant preferentially through the second flow passage via control over the adjusting means based on the measured temperature in a period in which circulation of the coolant is limited.
Patent MY-167849-A (MY)
Title: Aerosol-generating device and system
Inventor: GREIM OLIVIER
IPC: A24F40/90
Filed: 2012-12-28
Abstract: null
Patent MY-172136-A (MY)
Title: Coolant control valve apparatus
Inventor: TSUCHIYA TORU
Filed: 2013-05-14
Abstract: To provide a coolant control valve apparatus using a rotary valve that can suppress involvement of an extraneous material and can rotate a rotor even when such an extraneous material is involved. In an engine cooling system provided with a main channel (4) that connects an engine (1) and a radiator (3), a coolant control valve apparatus (10) that controls a flow rate of coolant water in the main channel (4) has a main valve (11) that is the rotary valve. The main valve (11) includes a rotor (12) and a casing (20) that has an inner peripheral surface facing an outer peripheral surface of this rotor (12), and a gap is provided between the outer peripheral surface of the rotor (12) and the inner peripheral surface of the casing (20). The inner peripheral surface of the casing (20) has a main opening part (30) that is connected to the main channel (4), and this main opening part (30) is provided with a sealing member that protrudes to the outer peripheral surface of the rotor (12) so as to be in touch with the outer peripheral surface of the rotor (12). This sealing member composes a channel that connects an opening part of the rotor (12) and an opening part of the casing (20).
Patent MY-186737-A (MY)
Title: Enhanced adhesion of seed layer for solar cell conductive contact
Inventor: WU JUNBO
IPC: H01L31/0216
Filed: 2013-11-27
Abstract: Enhanced adhesion of seed layers for solar cell conductive contacts and methods of forming solar cell conductive contacts are described. For example, a solar cell (200B), comprising: a substrate (200); an N-type emitter region (220) disposed above the substrate (200); and a conductive contact (228) disposed on and electrically connected to the N-type emitter region (220), the conductive contact (228) comprising a mixture of a metal paste portion and a P-type silicon portion (222), the metal paste portion and the P-type silicon portion (222) of the mixture in contact with the N-type emitter region (220). (Figure 2A)
Patent MY-192486-A (MY)
Title: Transporting belt and transporting device equipped with said transporting belt
Inventor: BUCH TORSTEN
IPC: B65G15/62
Filed: 2014-12-19
Abstract: A continuous transporting belt (1) has a multilayered structure. The multilayered structure includes at least a first layer (5) that forms a running side, and at least a second layer (6) that forms a load-bearing side. At least one of the layers is connected by an adhesion layer to at least one third layer (7) that forms at least one of a tension member and a further layer. The adhesion layer contains a composition having a first portion of an adhesive and a second portion of a lubricant. (FIG. 1)
Patent MY-176517-A (MY)
Title: Anti-cd38 antibodies for treatment of acute lymphoblastic leukemia
Inventor: PARUL DOSHI
Filed: 2015-02-25
Abstract: The disclosure relates to combination therapies using anti-CD38 antibodies. Specifically, it provides description methods of treating a subject having acute lymphoblastic leukemia (ALL), using an anti-CD38 antibody, wherein the anti- CD38 antibody induces death of ALL cells in vitro cytotoxicity mediated antibody dependent cell (ADCC), phagocytosis antibody dependent cellular (ADCP), complement dependent cytotoxicity (CDC), apoptosis, or modulation of enzyme activity of CD38 in vitro.
Patent MY-180427-A (MY)
Title: Vehicle
Inventor: HIROYUKI YOSHIKUNI
IPC: B62K5/08
Filed: 2016-09-28
Abstract: A vehicle (1) has a link mechanism (5), a steering force transmission mechanism (6), a steer lock mechanism (40) and a steer stopper mechanism (70). The steering force transmission mechanism (6) has a rear shaft member (60) that can turn about a rear axis a, a front shaft member (68) that can turn about a front axis b, and a connecting member (80) that transmits the turn of the rear shaft member (60) to the front shaft member (68). The steer lock mechanism (40) includes a first portion (42) and a second portion (41) which can be displaced relative to each other and makes it impossible for a right front wheel (32) and a left front wheel (31) to turn by making it impossible for the first portion (42) to be displaced relative to the second portion (41). The steer stopper mechanism (70) includes a third portion (71) and fourth portions (72, 73) which can be displaced relative to each other and restricts a maximum steering angle of the right front wheel (32) and the left front wheel (31) by stopping the relative displacement of the third portion (71) to the fourth portions (72, 73) so that the right front wheel (32) and the left front wheel (31) are prevented from being steered to more than the maximum steering angle. The first portion (42) and the third portion (71) are provided on the rear shaft member (60), and the second portion (41) and the fourth portions (72, 73) are provided on a member that is displaced relative to the rear shaft member (60).
Patent MY-180079-A (MY)
Title: Systems and methods for determining an angle of repose of an asymmetric lens
Inventor: FAN CHI SHING
Filed: 2016-03-23
Abstract: Technology to determine the angle of repose of a lens, such as the angle of repose of a contact lens on an eye, includes storing an image including the lens captured using a camera (142, 214) and executing graphical user interface logic. The graphical user interface logic includes a frame or frames including the captured image, and graphical constructs prompting input identifying a set of locations on the captured image that are usable to define a location of the lens in the image, and a location usable to define an angle of repose of the lens in the image. The input data accepted via the graphical user interface is processed to determine angle of repose of the lens. The angle of repose of the lens is used to produce a specification for a lens.
Patent MY-191511-A (MY)
Title: Fruit fly olfactory attractant composition and uses thereof
Inventor: RICHARD DREW
IPC: A01N37/02
Filed: 2013-10-03
Abstract: The present invention relates to an olfactory attractant composition for fruit flies and its use in methods of attracting fruit flies, controlling fruit flies and monitoring for the presence of fruit flies. In particular, the olfactory attractant composition comprises at least two lower alkyl esters of the formula C1-4alkylC(O)OC1-4alkyl. Dispensing devices for dispensing the composition and an apparatus for trapping fruit flies comprising the composition are also described.
Patent MY-188778-A (MY)
Title: A dye-sensitized solar cell
Inventor: NORASIKIN BINTI AHMAD LUDIN
Filed: 2018-12-31
Abstract: The present invention relates to a dye-sensitized solar cell, DSSC (100). The DSSC comprises of a first conductive substrate (10), a semiconductor (20) , a sensitizer (30), an electrolyte (40), a catalyst (50) and a second conductive substrate (60), wherein the sensitizer (30) is a combination of a natural dye and an inorganic dye.
Patent MY-195069-A (MY)
Title: Soldering alloy, soldering paste, preform solder, soldering ball, wire solder, resin flux cored solder, solder joint, electronic circuit board, and multi-layer electronic circuit board
Inventor: SHUNSAKU YOSHIKAWA
IPC: B23K35/14
Filed: 2020-05-11
Abstract: A soldering alloy comprising an alloy composition consisting of 13-22 mass% of In, 0.5-2.8 mass% of Ag, 0.5-5.0 mass% of Bi, 0.002-0.05 mass% of Ni, and a balance Sn. A soldering alloy, a soldering paste, a preform solder, a soldering ball, a wire solder, a resin flux cored solder and a solder joint, each of which is composed of the soldering alloy. An electronic circuit board (10, 20) and a multi-layer electronic circuit board (30, 31, 40) joined by using the solder joint (13, 14, 22, 36, 37, 43, 44).
Patent MY-182692-A (MY)
Title: A cutting tool
Inventor: TEOH SAI CHENG
Filed: 2011-05-05
Abstract: The present invention relates to a cutting tool for medical usage. More particularly for-cutting a gauze. The cutting tool comprises: a flat surface 10; a trolley unit 20 is connected downwardly to the flat surface 10; a cutting device 30 having a cutter 34 is fixed to the flat surface 10; characterized in that, a rolling mechanism 40 is connected to a side of the flat surface 10 for rolling the gauze; a pad 32 is connected to the cutting device 30 for controlling the cutter 34 wherein the cutter is placed in the cutting device 30 in a hidden position to avoid injury to a user.   The cutting device 30 is further comprising a pad 32 connected to the cutting device 30 wherein the pad 32 can be controlled using leg and consequently controlling the speed of the cutting device 30.   Most illustrative figure is Figure 1.
Patent MY-167323-A (MY)
Title: A luminaire assembly
Inventor: TAY KHENG HWEE
IPC: F21S8/00
Filed: 2013-11-22
Abstract: The present invention relates to a luminaire assembly (100), characterized by a mounting frame (110) having a bar (112) coupled thereto; a lighting unit (120) having a flange (121), wherein the flange (121) rests upon an upper surface of the mounting frame (110); a hinge extension (131) connected to a side of the lighting unit (120) opposite to that of the flange (121), and engaging with the bar (112) of the mounting frame (110); wherein a space is provided between the bar (112) and an inner surface of the hinge extension (131) to enable the lighting unit (120) to slide parallel to the mounting frame (110), thereby displacing the flange (121) from the mounting frame (110) and allowing the lighting unit (120) to swing away from the mounting frame (110). Drawing accompanying abstract: Fig. 1
Patent MY-194863-A (MY)
Title: Elevator
Inventor: JIANG HUA
IPC: H02P29/00
Filed: 2019-05-10
Abstract: The present utility model relates to an elevator, characterized by comprising: a door control motor (1), which drives opening and closing of the elevator door and has star-connected coils; and a door control board (2), which controls the driving of the door control motor (1) and has a temperature-rise monitoring mechanism (3) for monitoring a coil temperature of the door control motor (1), the temperature-rise monitoring mechanism (3) comprising a coil initial temperature acquiring unit (31), a coil initial resistance value calculation unit (34), a voltage measuring unit (32), a current measuring unit (33), a coil real-time resistance value calculation unit (35), and a temperature rise calculation unit (36), which calculates a temperature rise value of the coils according to the coil initial temperature, the coil initial resistance value and the coil real-time resistance value by using a resistance method. The coil temperature of the door control motor (1) is monitored in real time according to the temperature rise value.
Patent SG-10201704354Y-A (SG)
Title: Primer and probe set for detecting zika virus and kit thereof
Inventor: CHANG-YO HSUAN
IPC: C12Q1/70
Filed: 2017-05-29
Abstract: PRIMERAND PROBE SET FOR DETECTING ZIKA VIRUS AND KIT THEREOF OF THE DISCLOSURE The present invention provides a primer and probe set for detecting Zika virus, comprising a forward primer of SEQ ID NO: 1, a reverse primer of SEQ ID NO: 2, and a probe of SEQ ID NO: 3. Also provided is a kit for detecting Zika virus, comprising a primer and probe set of the present invention. Fig. 1 12
Patent SG-10201903538Y-A (SG)
Title: Modified virus-like particles of cmv
Inventor: BACHMANN MARTIN
Filed: 2015-10-20
Abstract: MODIFIED VIRUS-LIKE PARTICLES OF CMV The present invention relates to virus-like particles of plant virus Cucumber Mosaic Virus 5 (CMV), and in particular to modified VLPs of CMV comprising Th cell epitopes, in particular universal Th cell epitopes. Furthermore, these modified VLPs serve as, preferably, vaccine platform, for generating immune responses, in particular antibody responses, against antigens linked to said modified VLPs. The presence of the Th cell epitopes, in particular universal Th cell epitopes, led to a further increase in the generated immune response. 10 No Suitable Figure
Patent SG-10201909816P-A (SG)
Title: Methods of polynucleotide preparation using multivalent cation salt compositions
Inventor: RAMIYA PREMCHANDRAN
Filed: 2016-04-21
Abstract: METHODS OF POLYNUCLEOTIDE PREPARATION USING MULTIVALENT CATION SALT COMPOSITIONS Aspects of the disclosure include methods for the preparation of a polynucleotide. In some embodiments, the method includes contacting a first polynucleotide composition including: a polynucleotide having a sequence of 7 or more nucleoside subunits and at least two of the nucleoside subunits are joined by a N3′→P5′ thiophosphoramidate inter-subunit linkage; and non-target synthetic products and reagents; with a multivalent cation salt to precipitate a polynucleotide salt including at least one multivalent cation counterion; and separating the polynucleotide salt from the contacted first polynucleotide composition to produce a second polynucleotide composition including the polynucleotide salt. In certain embodiments, the method further includes contacting the polynucleotide salt with a reverse phase chromatography support; and eluting from the chromatography support a third polynucleotide composition including the polynucleotide. Also provided are compositions including a salt of the polynucleotide including at least one multivalent cation counterion. FIG. 2
Patent SG-11201804192S-A (SG)
Title: Composition for preventing or treating hair loss comprising chemokine (c-x-c motif) ligand 1 (cxcl1) protein
Inventor: SONG SUN UK
IPC: A61Q7/00
Filed: 2016-12-06
Abstract: OF THE DISCLOSURE Provided are a composition for preventing, treating or improving hair loss and a composition for promoting hair generation or hair growth, comprising a CXCL1 protein as an active ingredient, and a method using the same. The CXCL1 protein according to the present disclosure has no side effects at the time of treating hair loss and an 5 excellent hair generation effect even in a short time and thus can be used as pharmaceutical products and usefully used as quasi-drugs, cosmetics and health functional foods. 10
Patent SG-11201806292Q-A (SG)
Title: Pharmaceutical composition for preventing or treating diabetic nephropathy
Inventor: LEE JOO HAN
IPC: A61P13/12
Filed: 2016-01-27
Abstract: Pharmaceutical Composition for Preventing or Treating Diabetic Nephropathy A pharmaceutical composition of the present invention can 5 effectively prevent or treat diabetic nephropathy by blocking ， inhibiting or delaying, in advance, the onset of diabetic nephropathy; or alleviating diabetic nephropathy or inhibiting the progression of diabetic nephropathy. 10 [Figure 1]
Patent SG-11201810953V-A (SG)
Title: Production of activated clostridial neurotoxins
Inventor: LOVELOCK LAURA
IPC: C12P21/06
Filed: 2017-06-30
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 04 January 2018 (04.01.2018) W I PO I PCT omit VIII °nolo III IIIII 11o1o1111mmoiflom oimIE (10) International Publication Number WO 2018/002348 Al (51) International Patent Classification: TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, C12P 21/06 (2006.01) C07K 14/33 (2006.01) KM, ML, MR, NE, SN, TD, TG). A61K 38/48 (2006.01) (21) International Application Number: (22) International Filing Date: PCT/EP2017/066361 Published: — with international search report (Art. 21(3)) with sequence listing part of description (Rule 5.2(a)) 30 June 2017 (30.06.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 16177651.3 01 July 2016 (01.07.2016) EP (71) Applicant: IPSEN BIOPHARM LIMITED [GB/GB]; Unit 9 Ash Road - Wrexham Industrial Estate, WREXHAM LL13 9UF (GB). (72) Inventors: LOVELOCK, Laura; IPSEN BIOINNO- VATION LIMITED, 102 Park Drive - Milton Park, Abing- don Oxfordshire OX14 4RY (GB). KWAN, Daniel; IPSEN BIOINNOVATION LIMITED, 102 Park Drive - Mil- ton Park, ABINGDON Oxfordshire OX 14 4RY (GB). HORROCKS, Peter, Daniel; IPSEN BIOINNOVATION LIMITED, 102 Park Drive - Milton Park, Abingdon Ox- fordshire OX 14 4RY (GB). FIELD, Malgorzata; IPSEN BIOINNOVATION LIMITED, 102 Park Drive - Milton Park, Abingdon Oxfordshire OX 14 4RY (GB). MARKS, Philip; IPSEN BIOINNOVATION LIMITED, 102 Park Drive - Milton Park, Abingdon Oxfordshire OX 14 4RY (GB). (74) Agent: GROT, Emmanuelle et al.; Ipsen Pharma S.A.S., 65 quai Georges Gorse, 92100 Boulogne Billancourt (FR). = (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, co UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, O O 1-1 O (54) Title: PRODUCTION OF ACTIVATED CLOSTRIDIAL NEUROTOXINS \" (57) : The present invention relates to a method of producing activated clostridial neurotoxins that are essentially free of 0 unactivated products, to compositions comprising such and to their use in therapy.
Patent SG-11201811263W-A (SG)
Title: Molecular marker, reference gene, and application and test kit thereof, and method for constructing testing model
Inventor: GUO HONGYAN
IPC: C12N15/11
Filed: 2017-06-29
Abstract: OP10-0656 -40- Provided are a molecular marker, reference gene, and application and test kit thereof, and a method for constructing a testing model. Using follow-up information for a comparison method, the accuracy of the provided test kit in predicting the risk, in patients initially diagnosed as ER or PR positive for breast cancer, of recurrence or death 3-10 years after surgery is 70%, and accuracy in predicting a low-risk group and a high-risk group is 81.1% and 54.4%, respectively. The corresponding accuracies in predicting the FFPE pathology test results are 71.9% and 56.8%, respectively. The risk prediction model supporting the test kit requires only the Ct value of the molecular marker, the patient's age, the pT stage, and the LN quantity, and does not need to rely on other clinical pathology information; the model provides cancer prognosis assessment that is better than the pathology prediction result alone, and reduces to a certain extent the occurrence of improper treatment caused by erroneous pathology prediction, thus further improving the technical method for cancer prognosis assessment.